More importantly, overexpression of EGFR and insulin-like growth factor receptors enhances activation of PI3K/Akt/mTOR signaling in HCC, in which atypical PTEN activity upregulates activation of the PI3K/AKT/mTOR pathway (143). The gene discussed is PTEN; the disease is hepatocellular carcinoma.